Clinical trial
hUC-MSC-Exosomes for T2DM - Safety & Efficacy
NCT07693036
Study timeline
Study start (actual)2026-06-05Date precision: day
Registry last updated2026-07-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetes Mellitus (T2DM)unresolved
Interventions
exosomes treatment groupBIOLOGICAL
control groupOTHER
Sponsors & collaborators
Peking University First Hospitallead sponsor
ECHO Biotechcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07693036 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.